Martin Nobleza
Family · Houston, TXNPI 1083177661
Payments from drug & device makers
Across 358 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- Bayer$814
- Lilly USA, LLC$384
- Boehringer Ingelheim$345
- Radius Health, Inc.$314
- plus $2K from 29 others
What the payments were for
- Food & beverage$7,007100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 94 | $1,684 |
| AstraZeneca(2 entities) | 38 | $1,114 |
| Bayer | 44 | $814 |
| Lilly USA, LLC | 22 | $384 |
| Boehringer Ingelheim | 21 | $345 |
| Radius Health, Inc. | 15 | $314 |
| GSK | 17 | $301 |
| Paratek Pharmaceuticals, Inc. | 19 | $283 |
| Idorsia Pharmaceuticals US Inc | 7 | $186 |
| Amarin Pharma, Inc. | 7 | $144 |
| Amgen | 2 | $140 |
| Exact Sciences | 8 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $125 |
| AbbVie | 6 | $120 |
| Nestle Healthcare Nutrition Inc. | 3 | $114 |
| Sanofi Pasteur Inc. | 5 | $110 |
| Esperion Therapeutics, Inc. | 6 | $109 |
| Astellas Pharma US Inc | 5 | $89 |
| Sumitomo Pharma America, Inc. | 4 | $66 |
| Dexcom, Inc. | 3 | $65 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| IBSA Pharma Inc. | 2 | $35 |
| Genentech USA, Inc. | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Philips North America LLC | 2 | $30 |
| Johnson & Johnson | 2 | $26 |
| Merck | 2 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Mannkind Corporation | 1 | $20 |
| Biogen | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,007 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Houston
- Lashonda CraneHouston$3.4M
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- David WeirDallas$959K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.